Gene · 3691
Papers3,577
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,577
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prenatal Identification of a Novel ITGB4 Gene Mutation Associated With Junctional Epidermolysis Bullosa: A Case Report. | Clin Case Rep | 2026 | 41476816 | PubTator, text mining | PubMed |
| WTAP contributes to the malignancy and stemness of hepatocellular carcinoma through upregulating N6-methyladenosine modification of ITGB4. | Pathol Res Pract | 2026 | 41456451 | PubTator, text mining | PubMed |
| Lenvatinib and everolimus synergistically inhibit neuroendocrine neoplasms by upregulating ITGB4 expression. | Endocr Relat Cancer | 2026 | 41439601 | PubTator, text mining | PubMed |
| Integrin β4 drives immune evasion and therapeutic resistance to PD-1 blockade in bladder cancer via MEK/ERK signaling. | J Biol Chem | 2026 | 41241104 | PubTator, text mining | PubMed |
| Mechanisms of immune escape and extramedullary tropism in leukemia cutis. | Blood | 2026 | 41026928 | PubTator, text mining | PubMed |
| Nectin4-targeted molecular imaging in solid tumors: Current status and future perspectives. | View (Beijing) | 2025 | 42145938 | PubTator, text mining | PubMed |
| A novel variant c.A527G in ITGB4 leads to autosomal dominant epidermolysis bullosa in China. | Front Med (Lausanne) | 2025 | 41728014 | PubTator, text mining | PubMed |
| A four-gene signature from blood to exclude bacterial etiology of lower respiratory tract infection in adults. | Nat Commun | 2025 | 41285807 | PubTator, text mining | PubMed |
| Hemidesmosomes regulate epidermal differentiation during embryogenesis. | bioRxiv | 2025 | 41256674 | PubTator, text mining | PubMed |
| Construction and validation of an anoikis-related prognostic model for lung adenocarcinoma based on bulk and single-cell transcriptomic data. | PLoS One | 2025 | 41187171 | PubTator, text mining | PubMed |
| Photobiomodulation in fibroblasts: from light to healing through molecular pathways, omics and artificial intelligence. | Front Bioeng Biotechnol | 2025 | 41180838 | PubTator, text mining | PubMed |
| Artificial Intelligence-Assisted Nanosensors for Clinical Diagnostics: Current Advances and Future Prospects. | Biosensors (Basel) | 2025 | 41149307 | PubTator, text mining | PubMed |
Compound Heterozygous Null Variants in ITGB4 Gene Causing Severe Phenotype of Junctional Epidermolysis Bullosa With Pyloric Atresia in Thai Newborn: Genotype-Phenotype Correlation From a Case Report and Review of the Literature. | Int J Genomics | 2025 | 41035785 | PubTator, text mining | PubMed |
| Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer. | Cancer Gene Ther | 2025 | 41015572 | PubTator, text mining | PubMed |
| PERK protein kinase facilitates keratinocyte collective cell migration by engagement with cell adhesion molecules, independent of its kinase activity. | Mol Biol Cell | 2025 | 40991407 | PubTator, text mining | PubMed |
Measurement properties of instruments used to measure health-related quality of life in pediatric and adults patients with inherited epidermolysis bullosa: A systematic review and meta-analysis protocol. | PLoS One | 2025 | 40971360 | PubTator, text mining | PubMed |
| Integrated transcriptomic analysis identifies lactylation-linked gemcitabine resistance and therapeutic targets in intrahepatic cholangiocarcinoma. | Front Cell Dev Biol | 2025 | 40959663 | PubTator, text mining | PubMed |
| Controlling collagen I orientation on polyetheretherketone implants to improve epithelial sealing. | ACS Biomater Sci Eng | 2025 | 40925017 | PubTator, text mining | PubMed |
| A novel bladder phenotype in junctional epidermolysis bullosa: a case report. | Front Pediatr | 2025 | 40918660 | PubTator, text mining | PubMed |
| Recent advances in S-palmitoylation and its emerging roles in human diseases. | J Hematol Oncol | 2025 | 40890756 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3691/papers?page=4